Osaic Holdings
EVFM

Osaic Holdings’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Osaic Holdings’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-7,566
Closed -$7K – 7807
2022
Q2 		$7K Buy
7,566
+4,426
+141% +$7.3K ﹤0.01% 6359
2022
Q1 		$3.07M Sell
3,140
-281
-8% -$1.77K 0.01% 1574
2021
Q4 		$19K Sell
3,421
-1,766
-34% -$15K ﹤0.01% 5846
2021
Q3 		$58K Buy
5,187
+581
+13% +$7.3K ﹤0.01% 4995
2021
Q2 		$78K Buy
4,606
+219
+5% +$4.15K ﹤0.01% 4694
2021
Q1 		$116K Buy
4,387
+1,569
+56% +$71.3K ﹤0.01% 4233
2020
Q4 		$101K Buy
2,818
+377
+15% +$13.6K ﹤0.01% 4035
2020
Q3 		$86K Buy
2,441
+2,074
+565% +$90.2K ﹤0.01% 3934
2020
Q2 		$16K Buy
+367
New +$24.7K ﹤0.01% 4941

Other funds holding EVFM

CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Osaic Holdings's EVFM Position: Q3 2022 in Review

Osaic Holdings sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q3 2022, closing a stake of 7,566 shares — an estimated $7K sold.

Osaic Holdings first reported a position in EVFM in Q2 2020 and held it in 9 quarters. The position peaked at $3.07M in Q1 2022. 8 funds tracked by Wall St. Rank hold EVFM as of Q3 2022.

  • Osaic Holdings reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Osaic Holdings sold 7,566 Evofem Biosciences, Inc. Common Stock shares in Q3 2022, an estimated $7K.
  • Osaic Holdings first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2020 and held it in 9 quarters.
  • Osaic Holdings's Evofem Biosciences, Inc. Common Stock position peaked at $3.07M in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q3 2022.

Based on Osaic Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.